$13.61
-$0.01
(-0.07%)
Human Genome Sciences
NASDAQ:HGSI
Related Resources
HGSI
vs. S&P 500
|
$13.61
-$0.01
(-0.07%)
|
|
| Today's Open | $13.45 |
|---|---|
| Previous Close | $13.62 |
| Daily Range | $13.45 - $13.77 |
| 52-Week Range | $6.51 - $27.46 |
| Market Cap | $2.7B |
| P/E Ratio | -7.78 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,868,244 |
| Average Daily Volume | 9,263,632 |
| Current FY EPS | -$1.53 |
Sector
Healthcare
Industry
Biotechnology
Description
The drug development company with three products advancing into late-stage clinical development: Albuferon(r) for chronic hepatitis C, LymphoStat-B(r) for systemic lupus erythematosus, and ABthraxtm for anthrax disease.
